BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26248159)

  • 21. Platelet-derived growth factor up-regulates Ca
    Yamamura A; Nayeem MJ; Al Mamun A; Takahashi R; Hayashi H; Sato M
    FASEB J; 2019 Jun; 33(6):7363-7374. PubMed ID: 30865840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone demethylase JARID1B regulates proliferation and migration of pulmonary arterial smooth muscle cells in mice with chronic hypoxia-induced pulmonary hypertension via nuclear factor-kappa B (NFkB).
    Li Y; Liu S; Zhang Y; Gao Q; Sun W; Fu L; Cao J
    Cardiovasc Pathol; 2018; 37():8-14. PubMed ID: 30172777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin Signaling Through the 5-HT
    Hood KY; Mair KM; Harvey AP; Montezano AC; Touyz RM; MacLean MR
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1361-1370. PubMed ID: 28473438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway Suppression.
    Jia D; Zhu Q; Liu H; Zuo C; He Y; Chen G; Lu A
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28077433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin and chronic hypoxic pulmonary hypertension activate a NADPH oxidase 4 and TRPM2 dependent pathway for pulmonary arterial smooth muscle cell proliferation and migration.
    Song JL; Zheng SY; He RL; Gui LX; Lin MJ; Sham JSK
    Vascul Pharmacol; 2021 Jun; 138():106860. PubMed ID: 33794383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the phosphatidylinositol 3-kinase/Akt pathway is involved in lipocalin-2-promoted human pulmonary artery smooth muscle cell proliferation.
    Wang G; Ma N; Meng L; Wei Y; Gui J
    Mol Cell Biochem; 2015 Dec; 410(1-2):207-13. PubMed ID: 26350566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
    Xu Y; Sun Z; Wang Q; Wang T; Liu Y; Yu F
    Vascul Pharmacol; 2019 Sep; 120():106568. PubMed ID: 31207359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension.
    Jia D; He Y; Zhu Q; Liu H; Zuo C; Chen G; Yu Y; Lu A
    Cardiovasc Res; 2017 May; 113(6):586-597. PubMed ID: 28407046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of integrin-linked kinase in the hypoxia-induced phenotypic transition of pulmonary artery smooth muscle cells: Implications for hypoxic pulmonary hypertension.
    Hou J; Liu B; Zhu B; Wang D; Qiao Y; Luo E; Nawabi AQ; Yan G; Tang C
    Exp Cell Res; 2019 Sep; 382(2):111476. PubMed ID: 31255599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
    Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
    Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.
    Deng L; Blanco FJ; Stevens H; Lu R; Caudrillier A; McBride M; McClure JD; Grant J; Thomas M; Frid M; Stenmark K; White K; Seto AG; Morrell NW; Bradshaw AC; MacLean MR; Baker AH
    Circ Res; 2015 Oct; 117(10):870-883. PubMed ID: 26311719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Berberine attenuates pulmonary arterial hypertension via protein phosphatase 2A signaling pathway both in vivo and in vitro.
    Luo J; Gu Y; Liu P; Jiang X; Yu W; Ye P; Chao Y; Yang H; Zhu L; Zhou L; Chen S
    J Cell Physiol; 2018 Dec; 233(12):9750-9762. PubMed ID: 30078229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular Calpain/Calpastatin Balance Is Involved in the Progression of Pulmonary Hypertension.
    Wan F; Letavernier E; Abid S; Houssaini A; Czibik G; Marcos E; Rideau D; Parpaleix A; Lipskaia L; Amsellem V; Gellen B; Sawaki D; Derumeaux G; Dubois-Randé JL; Delcroix M; Quarck R; Baud L; Adnot S
    Am J Respir Cell Mol Biol; 2016 Sep; 55(3):337-51. PubMed ID: 26974350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
    Chen X; Yu X; Lian G; Tang H; Yan Y; Gao G; Huang B; Luo L; Xie L
    Biomed Pharmacother; 2024 May; 174():116505. PubMed ID: 38574614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained Activation of Rho GTPases Promotes a Synthetic Pulmonary Artery Smooth Muscle Cell Phenotype in Neprilysin Null Mice.
    Karoor V; Fini MA; Loomis Z; Sullivan T; Hersh LB; Gerasimovskaya E; Irwin D; Dempsey EC
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):154-163. PubMed ID: 29191928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.
    Sklepkiewicz P; Schermuly RT; Tian X; Ghofrani HA; Weissmann N; Sedding D; Kashour T; Seeger W; Grimminger F; Pullamsetti SS
    PLoS One; 2011 Apr; 6(4):e18883. PubMed ID: 21533110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.